Table 4.
Lowest- and highest-cost regimen for a 90-d supply of guideline-based12 medical therapy, including dispensing fee
| Variable | Lowest-cost regimen | Highest-cost regimen | ||
|---|---|---|---|---|
|
|
|
|||
| Drug | 90-d cost, $ | Drug | 90-d cost, $ | |
| Drug class | ||||
|
| ||||
| Angiotensin-converting-enzyme inhibitors | 90-d ramipril (generic) | 11.83 | 30-d lisinopril (brand-name) | 779.97 |
|
| ||||
| Antiplatelet agents | 90-d ASA (generic) | 10.35 | 30-d clopidogrel | 384.03 |
|
| ||||
| Direct factor Xa inhibitors | 90-d rivaroxaban (brandname) | 129.15 | NA | — |
|
| ||||
| Statins | 90-d rosuvastatin (generic) | 19.71 | 90-d atorvastatin (brand-name) | 384.30 |
|
| ||||
| Potential cost savings, $ | ||||
|
| ||||
| Total quarterly cost | 171.04 | 1548.30 | ||
|
| ||||
| Potential quarterly savings | 1377.26 | — | ||
|
| ||||
| Total monthly cost | 57.01 | 516.10 | ||
|
| ||||
| Potential monthly savings | 459.09 | — | ||
ASA = acetylsalicylic acid; NA = not applicable.